Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Neuromodulation for Comorbid Hoarding Disorder and Depression

NCT: NCT05985356 · COMPLETED

NCT IDNCT05985356
StatusCOMPLETED
Start Date2023-08-28
Completion2025-04-30
SponsorUniversity of California, San Diego (OTHER)
First posted
Last updated

Brief Summary

The primary goal of this study is to evaluate whether intermittent theta burst stimulation (iTBS) is effective for treating depression in people who have depression and chronic hoarding disorder (HD). The study will also evaluate whether this treatment can improve HD symptoms, cognitive performance, and brain region connectivity. The study team will investigate how the treatment works for depression, as well as other factors that can enhance or hinder treatment, such as pre-treatment level of depression, cognitive performance, or brain region connectivity.

Frequently Asked Questions

What is Neuromodulation for Comorbid Hoarding Disorder and Depression?

Neuromodulation for Comorbid Hoarding Disorder and Depression is a clinical trial registered under NCT05985356. Current status: COMPLETED.

What is the status of NCT05985356?

The current status of NCT05985356 (Neuromodulation for Comorbid Hoarding Disorder and Depression) is: COMPLETED.

When did Neuromodulation for Comorbid Hoarding Disorder and Depression start?

Neuromodulation for Comorbid Hoarding Disorder and Depression started on 2023-08-28.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.